Hutch News
Results per Page:
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of April 11, 2021
Two pathways, one destination: promising drug combination to treat ovarian cancer
From the Kemp Lab, Human Biology Division
Closer to the clinic: Modeling ovarian cancer metastases after surgery
From the Greenberg Lab, Clinical Research Division
New regional collaborations will accelerate innovation in data-intensive medical science
Three research teams in Washington, Oregon and British Columbia receive pilot funding from Cascadia Data Alliance
Fred Hutch research a GeekWire Award finalist for Health Innovation of the Year
Other finalists include Fred Hutch spinoffs Adaptive Biotechnologies and Blaze Bioscience
Scientists show thin metal mesh loaded with T cells shrinks solid tumors
Within weeks, CAR T cells targeting ovarian cancer cleared tumors in 70% of treated mice, shows study in Nature Biomedical Engineering. (Note: Images available for media use.)
Adoptive transfer of engineered T cells prolongs survival in preclinical ovarian cancer
From the Greenberg lab, Clinical Research Division, and the Vaccine and Infectious Disease Division
Nanotech turns pro-tumor immune cells into cancer-killing triple agents
Strategy doubles survival in mice with cancer
Eight promising projects win Evergreen Fund grants to promote commercialization of research
A dozen scientists to receive up to $200K from 3-year-old Fred Hutch program
Jenny Hansen: Two-time survivor, first-time Obliterider
‘I am so thankful there are people out there who aren’t afraid of cancer, who pursue it’
Timmerman headed for the top, again, with friends
Hutch expedition to Kilimanjaro has already raised $1 million
Dr. Holly Harris receives 2 grants to research endometriosis
Hutch public health researcher receives nearly $1.5 million to study endometriosis pain as well as the condition's connection to ovarian cancer
Dr. Kristin Anderson receives research grant from Ovarian Cancer Research Alliance
Anderson will use funds to expand research in boosting anti-tumor immune responses
When worry drives behavior
From M. Robyn Andersen, Public Health Sciences Division
Hutch science featured at world's premier cancer immunotherapy meeting
Researchers honored at SITC 2018 for work on immune-based treatments for leukemia, ovarian cancer, skin cancer
5 questions with a cancer immunotherapy expert
Dr. Phil Greenberg to receive high honor for his contributions to the field
Squelching ovarian cancer: the not-so-silent killer
The search continues for new biomarkers, better outcomes and, yes, cures for this deadly disease
Endometriosis linked to childhood abuse
New Fred Hutch collaboration highlights yet another poor health outcome associated with adverse childhood experiences
Immunotherapy strategy for ovarian cancer aims to rewire a ‘kill switch’ to ramp-up signal
T cells bearing a new engineered protein boost immunotherapy’s effectiveness in laboratory models of AML, ovarian, pancreatic cancers